Seminars in Oncology
Volume 33, Supplement 11 , Pages 36-38, December 2006

Is There a Third-Line Therapy for Metastatic Colorectal Cancer?

  • Axel Grothey

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Axel Grothey, MD, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN, 55905

Mayo Clinic College of Medicine, Rochester, MN

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Dr Grothey has served as a consultant for and received honoraria from Roche, Genentech, Bristol-Myers Squibb, and Sanofi-Aventis.

PII: S0093-7754(06)00384-8

doi:10.1053/j.seminoncol.2006.10.007

Seminars in Oncology
Volume 33, Supplement 11 , Pages 36-38, December 2006

Article Tools

* Image Usage & Resolution